Von Willebrand disease is an inherited condition where your blood does not clot properly, so you bleed more easily. There’s no cure but most people have mild symptoms that can be managed.
This study aims to assess the total and treated bleeding event rate in participants with von Willebrand Disease (VWD) on standard of care prophylaxis or on demand treatment, to identify potential participants and establish a historical comparator for future clinical studies.
Participant eligibility criteria
- Patients aged between 16-65
- Confirmed clinical diagnosis of von Willebrand disorder
